Anteris Technologies Ltd
ASX:AVR

Watchlist Manager
Anteris Technologies Ltd Logo
Anteris Technologies Ltd
ASX:AVR
Watchlist
Price: 9.2 AUD 2% Market Closed
Market Cap: 330.6m AUD
Have any thoughts about
Anteris Technologies Ltd?
Write Note

Gross Margin
Anteris Technologies Ltd

68.4%
Current
79%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
68.4%
=
Gross Profit
4.9m
/
Revenue
7.1m

Gross Margin Across Competitors

Country AU
Market Cap 330.6m AUD
Gross Margin
68%
Country JP
Market Cap 7T JPY
Gross Margin
86%
Country CH
Market Cap 37.8B CHF
Gross Margin
55%
Country DK
Market Cap 178.7B DKK
Gross Margin
68%
Country US
Market Cap 16.1B USD
Gross Margin
70%
Country KR
Market Cap 10.3T KRW
Gross Margin
15%
Country CN
Market Cap 49B CNY
Gross Margin
72%
Country US
Market Cap 6.5B USD
Gross Margin
65%
Country CA
Market Cap 6.4B USD
Gross Margin
61%
Country UK
Market Cap 4.7B GBP
Gross Margin
56%
Country US
Market Cap 5.7B USD
Gross Margin
47%
No Stocks Found

Anteris Technologies Ltd
Glance View

Market Cap
330.6m AUD
Industry
Health Care

Anteris Technologies Ltd. is a structural heart company, researches, develops, commercializes, and distributes various medical technologies and devices. The company is headquartered in Toowong, Queensland. The company went IPO on 2004-03-24. The firm is engaged in delivering solutions that help healthcare professionals. The firm operates through two segments: operations and projects. Operation segment provides Bio implant ADAPT operations inclusive of manufacturing and sales. Project segment includes Transcatheter Aortic Valve Replacement (TAVR), which is developed using ADAPT 3D single-piece technology and other development projects across the Company. The company offers two products, ADAPT and DurAVR. ADAPT technology is a BioScaffold, which is a tissue technology platform that demonstrates zero calcification. xenograft tissue into a pure collagen scaffold with optimized strength and pliability, biocompatibility and unparalleled durability. DurAVR heart valve Is focused on delivering a functional cure in the treatment of Severe Aortic Stenosis.

AVR Intrinsic Value
0.52 AUD
Overvaluation 94%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
68.4%
=
Gross Profit
4.9m
/
Revenue
7.1m
What is the Gross Margin of Anteris Technologies Ltd?

Based on Anteris Technologies Ltd's most recent financial statements, the company has Gross Margin of 68.4%.